The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
80 jobs Number of planned job losses
Announcement Date
14 January 2011
Employment effect (start)
14 January 2011
Foreseen end date
Description
On 14 January 2011, the biopharmaceutical company Innogenetics, located in Gent, announced the loss of 80 jobs, one- third of the current workforce. The dismissals procedure has already been launched. The job losses are announced six month after the buyout of the company by the Japanese group Fujirebio. The job reductions are blamed on the need to move away from research and development toward sales and distribution.
Sources
14 January 2011: L'Echo
Citation
Eurofound (2011), Innogenetics, Internal restructuring in Belgium, factsheet number 71465, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/71465.